Probiotics, Prebiotics, Synbiotics & Gut Nutrition

Next-Generation Probiotics and Therapeutics

Next-Generation Probiotics and Therapeutics is an advanced session that focuses on the future of microbiome-based interventions and innovative therapeutic strategies. Unlike traditional probiotics, next-generation probiotics include newly identified and scientifically validated microbial strains—such as Akkermansia muciniphila and Faecalibacterium prausnitzii—that have shown significant potential in improving metabolic health, reducing inflammation, and enhancing gut barrier function.

This session will explore how cutting-edge technologies like synthetic biology, genetic engineering, and precision medicine are being used to design targeted microbial therapies. These engineered probiotics can be tailored to deliver specific therapeutic molecules, regulate immune responses, or correct microbial imbalances associated with disease.

Experts will discuss clinical applications in chronic diseases, including metabolic disorders, inflammatory bowel disease, cancer, and neurological conditions. The session will also highlight microbiome-based therapeutics such as live biotherapeutic products (LBPs), fecal microbiota transplantation (FMT), and microbiome-derived metabolites.